Ovid Therapeutics Inc. (OVID) News Headlines

▮ More

Date

Headline

3/4/2021 2:21:01 AM KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

3/3/2021 7:05:33 AM Takeda Gets Global Rights At Closing From Ovid For Soticlestat For Dravet Syndrome, Lennox-Gastaut Syndrome

12/27/2020 9:33:59 PM Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run?

12/2/2020 6:16:53 AM Pre-market Movers In Healthcare Sector: ZOM, BNTX, PFE, MESO, OVID…

12/2/2020 2:11:23 AM OVID Plunges, VNDA's Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear

9/20/2020 1:19:07 AM Week Ahead In Pharma: Data Readouts, FDA Decision (AQST, BCRX, ETON...)

8/26/2020 1:37:03 AM CYCN To Report IW-6463 Data In Sep, IMVT Hits New High, SRPT On Watch, MDWD Keeps Word To BARDA

8/25/2020 8:00:47 AM Takeda Pharma Says Phase 2 ELEKTRA Study Of Soticlestat Met Primary Endpoint

8/25/2020 7:06:11 AM Takeda Pharma: Phase 2 ELEKTRA Study Of Soticlestat Meets Primary Endpoint

8/11/2020 1:57:59 AM CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs

7/13/2020 10:38:31 AM Stock Alert: Ovid Therapeutics Rises 6% After Partnering With Angelini Pharma

7/13/2020 9:04:02 AM Ovid And Angelini To Develop, Manufacture And Commercialize OV101 For Treatment Of Angelman Syndrome In Europe

7/13/2020 7:06:35 AM Ovid Therapeutics, Angelini Pharma Enter Exclusive License Agreement To Develop OV101

6/19/2020 8:05:15 AM Ovid Therapeutics Secures FDA Rare Pediatric Disease Designation For OV101

6/19/2020 1:52:36 AM FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars

5/7/2020 7:47:36 AM Ovid Says OV101 Met Study's Primary Objective Of Safety And Tolerability

3/24/2020 5:54:49 AM 9 Pharma/Biotech Stocks To Watch This Week, Here's Why...

5/30/2017 8:15:52 AM William Blair Starts Ovid Therapeutics Inc. (OVID) At Outperform

Older Articles